Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories Intl (NY: CRL ) 228.44 -3.66 (-1.58%) Streaming Delayed Price Updated: 3:19 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 254,285 Open 231.31 Bid (Size) 228.28 (2) Ask (Size) 228.63 (1) Prev. Close 232.10 Today's Range 225.58 - 232.18 52wk Range 161.65 - 275.00 Shares Outstanding 50,396,622 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally April 22, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing April 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Performance YTD -2.48% -2.48% 1 Month -14.99% -14.99% 3 Month +1.73% +1.73% 6 Month +38.85% +38.85% 1 Year +20.17% +20.17% More News Read More Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call April 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire Evaluating Charles River: Insights From 7 Financial Analysts March 18, 2024 Via Benzinga Forecasting The Future: 4 Analyst Projections For Charles River February 15, 2024 Via Benzinga Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology April 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics April 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River to Perform Plasmid Production for Ship of Theseus April 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Earnings Scheduled For February 14, 2024 February 14, 2024 Via Benzinga CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 02, 2024 From Bragar Eagel & Squire Via GlobeNewswire Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 April 01, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Publishes 2023 Corporate Citizenship Report March 27, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine March 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration March 14, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at Barclays Global Healthcare Conference March 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire The Top 3 Healthcare Stocks to Buy in March 2024 March 07, 2024 Via InvestorPlace Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy? March 07, 2024 Via InvestorPlace Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months March 06, 2024 Via Investor's Business Daily Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing February 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells February 20, 2024 From Charles River Laboratories International, Inc. Via Business Wire The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore. February 15, 2024 Via InvestorPlace Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday? February 14, 2024 Via Benzinga Topics Economy Exposures Interest Rates Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned February 14, 2024 Via Benzinga Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 14, 2024 Via Benzinga Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday February 14, 2024 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
